Research output per year
Research output per year
Personal profile
About
Dr. Yadollah Omidi joined Nova Southeastern University College of Pharmacy in August 2020 to work as a full professor of pharmaceutical sciences.
Dr. Omidi obtained his Ph.D. degree in the field of brain drug delivery and targeting from Cardiff University, United Kingdom, in 2003 and his Pharm.D. degree from Tabriz University of Medical Sciences (TUOMS), Iran, in 1991. He has completed a postdoctoral research associate program, studying gene-based nanomedicines and toxicogenomics at Cardiff University School of Pharmacy. As a professor of drug delivery and targeting, Dr. Omidi has several years of experience in teaching different subjects of pharmaceutical sciences and supervising Pharm.D., M.Sc., Ph.D., and M.D. students. He acted as the founding director of the TUOMS Research Center for Pharmaceutical Nanotechnology. He is the founding Editor-in-Chief of Bioimpacts, and also serves on the editorial board of several international journals, including Nanomedicine, Biologicals, DARU Journal of Pharmaceutical Sciences, and BMC Pharmacology and Toxicology. Dr. Omidi is a collaborator of several scientists from the U.S., and Europe. In 2011, he joined the Ovarian Cancer Research Center at the University of Pennsylvania (United States) as a visiting associate professor to undertake translational research towards the development of multifunctional nanomedicines and theranostics for targeted therapy of ovarian cancer with a particular focus on drug targeting of the tumor microenvironment.
Dr. Omidi's research interests are focused on different areas of pharmaceutical sciences, including drug delivery and targeting, multifunctional nanomedicines and theranostics, biological membranes and barriers, vaccines and immunotherapeutics, nanobiomaterials for cell/tissue engineering, and diagnostic nanobiosystems. Since 2003, Dr. Omidi has published over 330 papers in peer-reviewed international journals. He is also the author of 30 book chapters and the recipient of several teaching and research awards. Listed among the top 1% of scientists worldwide by the ESI-WoS, he has an h-index of 65 and an i10-index of 251 with over 14550 citations.
Teaching
PHRP-8250: Advanced Topics in Pharmaceutical Sciences
PHRE-5210: Modern Medicine
PHRC-4850: Pharmaceutical Calculations
Related documents
Education/Academic qualification
Ph.D., Pharmaceutical Sciences, Cardiff University - United Kingdom
1999 → 2003
Pharm.D., Tabriz University of Medical Sciences
1986 → 1991
External positions
Founding Head, Tabriz University of Medical Sciences Biomedicine Institute
2017 → 2018
Founding Director, HopePharmTech
2016 → …
Full Professor, Tabriz University of Medical Sciences
2014 → 2019
Founding Head, National Institute of Medical Research
2013 → 2017
Associate Professor, Tabriz University of Medical Sciences
2013 → 2014
Founding Editor-in-Chief, Bioimpacts
2011 → …
Visiting Associate Professor, University of Pennsylvania
2011 → 2013
Advisory Board Member, Tabriz University of Medical Sciences
2010 → 2013
Associate Professor, Tabriz University of Medical Sciences
2008 → 2011
Founding Dean, Tabriz University of Medical Sciences School of Advanced Biomedical Sciences
2008 → 2010
Principal Investigator, Tabriz University of Medical Sciences
2005 → 2018
Assistant Professor, Tabriz University of Medical Sciences
2004 → 2008
Postdoctoral Research Associate, Cardiff University - United Kingdom
2003 → 2004
Lecturer, Tabriz University of Medical Sciences
1991 → 1998
Research Interests
- drug delivery and targeting
- multifunctional nanomedicines and nanobiomaterials
- Theranostics
- Biological membranes and barriers
- vaccines and immunotherapies
- diagnostic nanobiosystems
Disciplines
- Pharmacy and Pharmaceutical Sciences
Fingerprint
Dive into the research topics where Yadollah Omidi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Biomarker-driven and AI-assisted nanomedicine for breast cancer: advancing precision drug delivery from bench to bedside
Barar, J., Ansari, R. & Omidi, Y., 2026, In: Expert Opinion on Drug Delivery. 23, 8, p. 1447-1477 31 p.Research output: Contribution to journal › Review article › peer-review
1 Link opens in a new tab Scopus citations -
Bridging Preclinical and Clinical Gaps in Ocular Therapeutics: Hydrogel Drug Delivery and 3D Tissue Models
Barar, J., Aliakbari, A. & Omidi, Y., 2026, In: International Journal of Nanomedicine. 21, 555555.Research output: Contribution to journal › Review article › peer-review
Open AccessFile3 Link opens in a new tab Scopus citations -
Circular RNAs in microalgae: Uncovering their biological significance
Dehghani, J., Panahi, B., Nolsøe, J. M. J., Lerouge, P., Bardor, M. & Omidi, Y., Jan 1 2026, In: Biotechnology Advances. 86, 108739.Research output: Contribution to journal › Article › peer-review
1 Link opens in a new tab Scopus citations -
Emerging advancements and expanding technological scope of education and practices in pharmacy and pharmaceutical sciences
Barar, J., Fiano, K., Seamon, M., Albensi, B., Khanfar, N. & Omidi, Y., 2026, In: BioImpacts. 16, 33047.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Gold nanoparticle-modified graphene oxide electrochemical aptasensor for ultrasensitive detection of interferon gamma in kidney transplants
Hosseini, N., Nakhjavani, S. A., Ardalan, M., Salimi, A., Adibkia, K. & Omidi, Y., Jun 2026, In: Bioelectrochemistry. 169, 109207.Research output: Contribution to journal › Article › peer-review
3 Link opens in a new tab Scopus citations
Press/Media
-
Recent Findings from NOVA Southeastern University Advance Knowledge in Bioinformatics (A novel pairwise sequence alignment algorithm for similarity search in massive datasets)
10/13/25
1 item of Media coverage
Press/Media: Research